EDGAR Filing Documents for 0001193125-23-204493

Form 8-K - Current report:

SEC Accession No. 0001193125-23-204493

Filing Date

2023-08-07

Accepted

2023-08-07 08:02:59

Documents

Period of Report

2023-08-04

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d469204d8k.htm iXBRL	8-K	52628
2	EX-2.1	d469204dex21.htm	EX-2.1	580185
3	EX-3.1	d469204dex31.htm	EX-3.1	73449
4	EX-10.1	d469204dex101.htm	EX-10.1	114041
5	EX-99.1	d469204dex991.htm	EX-99.1	19435
	Complete submission text file	0001193125-23-204493.txt		1174628

Data Files

Seq	Description	Document	Type	Size
6	XBRL TAXONOMY EXTENSION SCHEMA	ikna-20230804.xsd	EX-101.SCH	2868
7	XBRL TAXONOMY EXTENSION LABEL LINKBASE	ikna-20230804_lab.xml	EX-101.LAB	20245
8	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	ikna-20230804_pre.xml	EX-101.PRE	12614
10	EXTRACTED XBRL INSTANCE DOCUMENT	d469204d8k_htm.xml	XML	3804

Mailing Address 50 NORTHERN AVE. BOSTON MA 02210

Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292

Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)